Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.

Chen M, Zhang X, Chen Y, Sun W, Wang Z, Huang C, Hu G, Chen R.

Xenobiotica. 2019 Jul 3:1-8. doi: 10.1080/00498254.2019.1628321. [Epub ahead of print]

PMID:
31199171
2.

Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat.

Lin G, Wang C, Qiu X, Wang Z, Han A, Xu T, Kan X, Hu G.

Drug Dev Ind Pharm. 2014 Dec;40(12):1616-22. doi: 10.3109/03639045.2013.838582. Epub 2013 Sep 20.

PMID:
24053419
3.

Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats.

Lou D, Cui X, Bao SS, Sun W, Pan WH, Chen MC, Dong YY, Hu GX, Chen RJ, Wang Z.

Drug Dev Ind Pharm. 2019 Apr;45(4):689-693. doi: 10.1080/03639045.2019.1569042. Epub 2019 Jan 24.

PMID:
30632818
4.

Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).

Gupta A, Unadkat JD, Mao Q.

J Pharm Sci. 2007 Dec;96(12):3226-35.

PMID:
17518356
6.

The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes.

Luo X, Li T, Yu Z, Xue X, Zhao H, Li N, Ma L, Yang C, Huang L, Feng W.

Xenobiotica. 2019 Jul;49(7):753-761. doi: 10.1080/00498254.2018.1473662. Epub 2019 Mar 25.

PMID:
29770723
7.

Inhibitory effect of ketoconazole and voriconazole on the pharmacokinetics of carvedilol in rats.

Wang L, Wang S, Chen M, Chen X, Lin Y, Hu X, Huang X, Li X, Hu G.

Drug Dev Ind Pharm. 2015;41(10):1661-6. doi: 10.3109/03639045.2014.983930. Epub 2014 Nov 24.

PMID:
25417773
8.

Inhibitory effect of isavuconazole, ketoconazole, and voriconazole on the pharmacokinetics of methadone in vivo and in vitro.

Shen L, Wang J, Yi Y, Ye C, Wang R, Xia G, Yu C, Tu F, Xu J, Zheng Z.

Drug Test Anal. 2019 Apr;11(4):595-600. doi: 10.1002/dta.2534. Epub 2018 Dec 25.

PMID:
30370647
9.

Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen.

Chen L, Zhu L, Li M, Li N, Qi F, Wang N.

AAPS PharmSciTech. 2019 Jan 2;20(1):24. doi: 10.1208/s12249-018-1219-5.

PMID:
30604153
10.

Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).

Warrilow AG, Martel CM, Parker JE, Melo N, Lamb DC, Nes WD, Kelly DE, Kelly SL.

Antimicrob Agents Chemother. 2010 Oct;54(10):4235-45. doi: 10.1128/AAC.00587-10. Epub 2010 Jul 12.

11.

Origin of differences in susceptibility of Candida krusei to azole antifungal agents.

Marichal P, Gorrens J, Coene MC, Le Jeune L, Vanden Bossche H.

Mycoses. 1995 Mar-Apr;38(3-4):111-7.

PMID:
7477085
13.

Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.

Greenblatt DJ, von Moltke LL, Harmatz JS, Mertzanis P, Graf JA, Durol AL, Counihan M, Roth-Schechter B, Shader RI.

Clin Pharmacol Ther. 1998 Dec;64(6):661-71.

PMID:
9871431
14.

[Drug-drug interaction of antifungal drugs].

Niwa T, Shiraga T, Takagi A.

Yakugaku Zasshi. 2005 Oct;125(10):795-805. Review. Japanese.

15.

[In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].

Blanco MT, Cañadas J, García-Martos P, Marín P, García-Tapia A, Rodríguez J.

Rev Esp Quimioter. 2009 Sep;22(3):139-43. Spanish.

16.

Comparative Hepatotoxicity of Fluconazole, Ketoconazole, Itraconazole, Terbinafine, and Griseofulvin in Rats.

Khoza S, Moyo I, Ncube D.

J Toxicol. 2017;2017:6746989. doi: 10.1155/2017/6746989. Epub 2017 Feb 5.

17.

Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.

Panackal AA, Gribskov JL, Staab JF, Kirby KA, Rinaldi M, Marr KA.

J Clin Microbiol. 2006 May;44(5):1740-3.

18.

In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.

Jesus FP, Lautert C, Zanette RA, Mahl DL, Azevedo MI, Machado ML, Dutra V, Botton SA, Alves SH, Santurio JM.

Vet Microbiol. 2011 Aug 26;152(1-2):161-4. doi: 10.1016/j.vetmic.2011.04.027. Epub 2011 Apr 22.

PMID:
21658868
19.

Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.

Arzeni D, Barchiesi F, Ancarani F, Scalise G.

J Chemother. 1991 Jun;3(3):139-42.

PMID:
1655990
20.

Single- and multiple-dose pharmacokinetics of bosentan and its interaction with ketoconazole.

van Giersbergen PL, Halabi A, Dingemanse J.

Br J Clin Pharmacol. 2002 Jun;53(6):589-95.

Supplemental Content

Support Center